| HOME >> BIOLOGY >> TECHNOLOGY |
Veridex Acquires Immunicon II-51
Thermo Fisher Takes Over nAscent II-52
Labcyte and Deerac Fluidics Combine Operations II-52
Invitrogen and Applied Biosystems Merge to Form Life Technologies II-52
Insert Therapeutics Merges with Calando Pharmaceuticals II-52
Capsulution Nanoscience and NanoDel Technologies Merge II-53
BioForce Forms Collaboration with UAlbany NanoCollege II-53
Advion and Bruker Daltonik Enter into Joint Marketing Agreement II-53
Midatech Group Inks Agreement with MonoSol Rx II-53
Advion Signs Co-Marketing Agreement with Agilent Technologies II-54
Abraxis Inks Deal to Re-Acquire US Rights to Abraxane II-54 NanoKTN and Bio Nano to Develop Nanomedicine II-54
Evolved Machines Inks License Contract with Nanosys II-54
Abraxis Bags European Commission Approval to Market Abraxane II-55
Nanogen Eyes European Molecular Diagnostics Market II-55
Abraxis Receives Approval for Marketing ABRAXANE in Korea and China II-55
BioForce Receives MIT Validation for Nano eNabler Molecular Printer II-55
Oxonica and Becton, Dickinson and Co. Sign Strategic Deal II-55
Nanogen Sells Royalties to DRI Capital II-56
Nanogen Signs Deal with Thermo Fisher II-56
Midatech Establishes New Nanotechnology Subsidiary II-56
Nanogen and HX Diagnostics Extend Collaboration II-57
CytImmune Joins Hands with University of Maryland II-57
Abraxis Inks Licensing Deal with Japan's Taiho II-57
Abraxis Files Marketing Application for Abraxane in Japan II-58
BioForce Secures State Funding for ViriChip(TM) II-58
Capsulution and Advanced Materials Ink Patent License Deal II-58
Midatech Bags US Grant on Patent Application II-59
Nanobiotix Wins European Patent for Activable Particles II-59
Nanotherapeutics Submits IND Application for N
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |